Debut is a biotech beauty startup that is revolutionizing the beauty industry by shifting from traditionally sourced ingredients to high-performing and sustainable biotech ingredients. Founded in 2019, the company is headquartered in the United States. Their mission is to set a new beauty standard based on potency, purity, and performance.
As a fully vertically-integrated global company, Debut creates superior, scientifically-engineered, bio-based and clinically-proven products and brands at scale to benefit both people and the planet. Their innovative approach has attracted significant investment, including a recent $40.00M Series B investment on 02 June 2023.
The investors in this latest round include Cultivian Sandbox, GS Futures, Material Impact, ACVC Partners, Cavallo Ventures, Fine Structure Venture, and Business Opportunities for L'Oréal Development. With its unique positioning in the biotechnology and consumer goods industries, Debut has positioned itself as a leader in redefining beauty through sustainable and high-performance biotech ingredient solutions.
No recent news or press coverage available for Debut.